Correlation Between Neurobo Pharmaceuticals and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Lixte Biotechnology.
Diversification Opportunities for Neurobo Pharmaceuticals and Lixte Biotechnology
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neurobo and Lixte is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Lixte Biotechnology
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 1.4 times less return on investment than Lixte Biotechnology. But when comparing it to its historical volatility, Neurobo Pharmaceuticals is 5.08 times less risky than Lixte Biotechnology. It trades about 0.58 of its potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 222.00 in Lixte Biotechnology Holdings on November 2, 2024 and sell it today you would earn a total of 26.00 from holding Lixte Biotechnology Holdings or generate 11.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 15.79% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Lixte Biotechnology |
Neurobo Pharmaceuticals and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Lixte Biotechnology
The main advantage of trading using opposite Neurobo Pharmaceuticals and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |